Sodium-glucose co-transporter 2 inhibitors & glucagon-like peptide-1 receptor agonists, efficacy & safety in diabetic kidney transplant recipients.

Mahmoud, Tarek; Yagan, Jude; Hasan, Amal; Gheith, Osama A; Mostafa, Mohamed; Rida, Suzann; El-Serwi, Nabil; Shaker, Mohamad; Khalid, Mahmoud

Mahmoud, Tarek; Yagan, Jude; Hasan, Amal; Gheith, Osama A; Mostafa, Mohamed; Rida, Suzann; El-Serwi, Nabil; Shaker, Mohamad; Khalid, Mahmoud.

Afiliação

Mahmoud T; Nephrology Department, Jaber Al Ahmed Armed Forces Hospital, Subhan, Kuwait.
Yagan J; Nephrology Department, Hamed Al-Essa Organ Transplant Center, Sabah Medical Region, Kuwait City, Kuwait.
Hasan A; Nephrology Department, Jaber Al Ahmed Armed Forces Hospital, Subhan, Kuwait.
Gheith OA; Nephrology Department, Hamed Al-Essa Organ Transplant Center, Sabah Medical Region, Kuwait City, Kuwait.
Mostafa M; Department of Translational Research, Dasman Diabetes Institute, Dasman, Kuwait.
Rida S; Nephrology Department, Hamed Al-Essa Organ Transplant Center, Sabah Medical Region, Kuwait City, Kuwait.
El-Serwi N; Nephrology Department, Hamed Al-Essa Organ Transplant Center, Sabah Medical Region, Kuwait City, Kuwait.
Shaker M; Nephrology Department, Hamed Al-Essa Organ Transplant Center, Sabah Medical Region, Kuwait City, Kuwait.
Khalid M; Nephrology Department, Hamed Al-Essa Organ Transplant Center, Sabah Medical Region, Kuwait City, Kuwait.

Clin Transplant ; 37(12): e15144, 2023 12.

Article em En | MEDLINE | ID: mdl-37755118

Assuntos

Diabetes Mellitus Tipo 2; Transplante de Rim; Inibidores do Transportador 2 de Sódio-Glicose; Simportadores; Humanos; Inibidores do Transportador 2 de Sódio-Glicose/uso terapêutico; Inibidores do Transportador 2 de Sódio-Glicose/farmacologia; Hipoglicemiantes/uso terapêutico; Agonistas do Receptor do Peptídeo 1 Semelhante ao Glucagon; Diabetes Mellitus Tipo 2/tratamento farmacológico; Hemoglobinas Glicadas; Transplante de Rim/efeitos adversos; Albuminúria; Simportadores/uso terapêutico; Glucose; Sódio/uso terapêutico

Palavras-chave

diabetes; glucagon-like peptide-1 receptor agonists (GLP-1 RA); kidney transplantation; outcome; sodium-glucose co-transporter 2 inhibitors (SGLT2i)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Rim / Simportadores / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google